Park Dental Partners, Inc. 8-K Filing

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share PARK The Nasdaq Stock Mar
• $13.00 — Stock"), at a public offering price of $13.00 per share, pursuant to the Company's re
• $0.91 — ing discount of 7% of the IPO Price, or $0.91 per share of Common Stock. Pursuant to

Filing Documents

• tm2514579d20_8k.htm (8-K) — 33KB
• tm2514579d20_ex1-1.htm (EX-1.1) — 222KB
• tm2514579d20_ex4-1.htm (EX-4.1) — 60KB
• tm2514579d20_ex99-1.htm (EX-99.1) — 9KB
• tm2514579d20_ex99-2.htm (EX-99.2) — 9KB
• 0001104659-25-118514.txt ( ) — 574KB
• park-20251204.xsd (EX-101.SCH) — 3KB
• park-20251204_lab.xml (EX-101.LAB) — 33KB
• park-20251204_pre.xml (EX-101.PRE) — 22KB
• tm2514579d20_8k_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On December 2 , 2025, Park Dental Partners, Inc. (the "Company") priced the initial public offering (the "IPO") of its common stock, par value $0.0001 per share (the "Common Stock"), at a public offering price of $13.00 per share, pursuant to the Company's registration statement on Form S-1 (File No. 333-290001), as amended (the "Registration Statement"), which was declared effective by the Securities and Exchange Commission on December 2, 2025 (the "Effective Date"). The IPO closed and the Common Stock was delivered on December 4, 2025. On December 2 , 2025, in connection with the pricing of the IPO, the Company and Northland Securities, Inc. (the "Representative"), as representative of the several underwriters (the "Underwriters"), entered into an underwriting agreement (the "Underwriting Agreement"), pursuant to which the Company agreed to offer and sell, and the Underwriters agreed to purchase, 1,535,000 shares of the Common Stock. Pursuant to the Underwriting Agreement, the Company also: (i) agreed to issue to the Representative or its designees a warrant to purchase shares of Common Stock equal to 6.0% of the aggregate number of shares of Common Stock sold in the IPO (the "Warrant"), pursuant to a warrant agreement in substantially the form attached to the Underwriting Agreement (the "Warrant Agreement"); and (ii) granted the Underwriters a 30-day option to purchase up to an additional 230,250 shares of Common Stock. The Underwriting Agreement also provides for an underwriting discount of 7% of the IPO Price, or $0.91 per share of Common Stock. Pursuant to the Warrant Agreement, the Warrant will be exercisable at 120% of the IPO Price and may be exercised on a cashless basis. The Warrant is exercisable at any time and from time to time, in whole or in part, during the five-year period commencing on the Effective Date. Pursuant to applicable rules of the Financial Industry Regulatory Authority ("FINRA"),

01 Other Events

Item 8.01 Other Events. On December 2, 2025, the Company issued a press release announcing the pricing of the IPO. A copy of this press release is attached hereto as Exhibit 99.1. On December 4, 2025, the Company issued a press release announcing the closing of the IPO. A copy of this press release is attached hereto as Exhibit 99.2. The information provided under this Item 8.01, including the accompanying press releases, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section. This information will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) The following exhibits are being filed herewith: Exhibit No. Description 1.1 Underwriting Agreement, dated December 4 , 2025, by and between Park Dental Partners, Inc. and Northland Securities, Inc., as representative of the underwriters. 4.1 Form of Representatives' Warrant 99.1 Press Release, dated December 2 , 2025, announcing pricing of IPO. 99.2 Press Release, dated December 4 , 2025, announcing closing of IPO. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 4 , 2025 PARK DENTAL PARTNERS, INC. By: /s/ Peter G. Swenson Name: Peter G. Swenson Title: Chief Executive Officer Date: December 4, 2025

View Full Filing

View this 8-K filing on SEC EDGAR